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ABSTRACT
The research in this dissertation focuses on developing a novel methodology for ChIP-
Seq dataset analysis. Despite its advances, the standard ChIP-Seq data analysis pipeline, i.e.,
read mapping followed by peak calling has the following shortcomings:
1. Majority of the ChIP-Seq dataset consists of background reads, hence unnecessary
computation effort is spent on mapping reads that have no role in forming the true
peaks.
2. Unnecessary computation effort is spent on aligning control reads which do not map
to ChIP-enriched genomic regions.
3. Multi-mappable reads are often discarded during the read mapping, resulting in the
reduced power to identify peaks in repeat elements of the genome.
We present Map2Peak, a novel tool aimed at mitigating the aforementioned drawbacks.
Map2Peak receives ChIP-Seq and control unmapped reads as the input and presents the
peaks as the output at a speed twice faster than that of standard workflow. Map2Peak inter-
twines partial read mappings and peak calling in a five-phase algorithm. It models the frag-
ment count information obtained during the early stages of ChIP read mapping (Phase 1) as
a 2-component Poisson mixture model, and then implements expectation-maximization al-
gorithm to identify ChIP enriched regions (Phase 2). The remaining ChIP reads and majority
of control reads are then restricted to map exactly only to the much shorter pseudo-genome
composed of the ChIP enriched regions (Phase 3 & 4). The mapping information is then
used to call peaks on pseudo-genome (Phase 5). Our results show that the peaks called by
Map2Peak encompass most of the peaks called by the standard workflow (88%-96%) and
some novel motif-justifiable peaks which are not detected by the standard workflow, and
majority (90%) of the background reads are discarded. Moreover, Map2Peak implicitly re-
solves the alignment location for some of the multi-mappable reads which result in increased
ii
power to call peaks in repeat elements of the genome.
Map2Peak provides researchers with an ultrafast peak caller which utilizes whole
ChIP-Seq dataset without discarding multi-mappable reads to identify peaks, and effi-
ciently utilize control datasets for the purpose of peak calling. “Map2Peak” is available
at https://kianfar.engr.tamu.edu/map2peak/.
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1. INTRODUCTION
In this research we developed a novel methodology for ChIP-Seq (Chromatin Immuno-
precipitation followed by Sequencing) data analysis which is both fast and can accurately
exploit multi-mappable sequencing reads, i.e., reads that can be mapped to multiple loca-
tions on the genome. ChIP-Seq is a biological assay used to detect genomic locations of
protein-DNA binding and histone modification events. Identification of these genomic loca-
tions further the understanding of biological processes of the cell such as cell differentiation,
cell cycle propagation, gene regulation, chromosome stability, and epigenetic silencing, etc
and also provide insights into abnormal cellular states which cause diseases [13]. These
insights leads to development of better diagnosis and treatment of disease [14]. Study of
protein-DNA interactions is one of the important research topics in genomics.
To understand the scope of this research, a brief introduction on cell biology and biolog-
ical data generation and analysis is necessary.
In general, a eukaryote cell consists of a dense membrane bound structure called the nu-
cleus and other membrane bound distinct structures called organelles (Figure 1.1 (on right)).
The nucleus contains the chromosomes which in turn contain the genetic material, DNA
(DeoxyriboNucleic Acid). In prokaryote, DNA is not stored inside a nucleus (Figure 1.1 (on
left)).
Genetic information is stored in DNA as a double helical structure (Figure 1.2) containing
two long polynucleotide chains, each of which is composed of four types of subunits called
nucleotides. Each of these chains are called DNA strand [2]. The four different nucleotides
are composed of sugar-phosphate group and a nitrogen-containing base. Each nucleotide is
defined by a specific nitrogenous base; Adenine (A), Thymine (T), Cytosine (C) and Guanine
(G). The two strands are arranged such that every nucleotide base within one strand is paired
with complementary nucleotide base within another strand through hydrogen bonds. The two
set of complementary base pairs are Adenine-Thymine (A-T) and Guanine-Cytosine (G-C)
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Figure 1.1: Cell organelles in prokaryotes (on left) and in eukaryotes (on right). Reprinted
with permission from [1].
(Figure 1.2). As a result one strand of DNA is exactly complementary to the nucleotide
sequence of another strand of DNA. The two strands are antiparallel to each other, i.e., the
polarity (direction) of one strand is oriented in the opposite direction to that of the other
strand. The polarity (direction) in a DNA strand is shown by referring one end as 5′ end and
the other as 3′ end. This means that one DNA strand runs in 5′ to 3′ direction and another
runs in 3′ to 5′ direction (Figure 1.2) [2].
DNA is stored in a compact structure called chromatin whose function is to compress
DNA into a compact unit so that it can fit inside the nucleus. The packaging of DNA inside
the nucleus also plays an important role in cell functioning.
The flow of genetic information from DNA to protein takes place inside the cell through
the transcription process followed by the translation process (Figure 1.3). Transcription is
the process in which a piece of DNA is copied into mRNA (messenger ribonucleic acid).
The piece of DNA which is copied into mRNA is called a gene, which encodes for a specific
protein. RNA like DNA is also made up of chain of nucleotides. The process of converting
mRNA into proteins is called translation. Proteins are complex molecules which are required
for the structure, function and regulation of cells.
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Figure 1.2: DNA, double helix structure. Reprinted with permission from [2]. From
MOLECULAR BIOLOGY OF THE CELL, FOURTH EDITION by Bruce Alberts, et al.
Copyright c©2002 by Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith
Roberts, and Peter Walter. c©1983, 1989, 1994 by Bruce Alberts, Dennis Bray, Julian Lewis,
Martin Raff, Keith Roberts, and James D. Watson. Used by permission of W.W. Norton &
Company, Inc.
This flow of information from DNA to protein via RNA is tightly controlled within each
cell. Cell can control the level of protein being synthesized by controlling the amount of
genes that are expressed during transcription [3]. This process control is called transcrip-
tion regulation. In a cell, among various methods to control transcription, are Transcription
Factors (TFs) and chromatin modifications. Transcription factors are the proteins which can
control (increase, decrease or suppress) transcription by interacting with DNA [3]. Each TF
binds to a specific DNA sequence called motif. Chromatin modifications change the packag-
ing of DNA which affects the accessibility of genes for transcription and hence regulate the
3
Figure 1.3: Flow of genetic information from DNA to protein in an eukaryotic cell. Reprinted
with permission from [3].
process [15]. One way of altering chromatin packaging is through histone modifications. Hi-
stone are the proteins which act to package DNA, which wraps around eight histone proteins
to form chromatin (Figure 2.1). TF-DNA interactions and histone modifications play impor-
tant role in maintaining cell states. Misregulation of transcription can initiate and propagate
diseases [16]. Many different diseases such as cancer, diabetes and neurological disorders
can be caused by mutations in transcription factors and chromatin regulators [16].
Transcription regulation through TF-DNA interactions and histone modifications is an
important research area in Bioinformatics. To study genome-wide protein-DNA interac-
tions, Chromatin Immunoprecipitation (ChIP) is performed, Chromatin Immunoprecipita-
tion (ChIP) is a chemical technique to generate DNA fragments which are used to study
genome-wide protein-DNA interactions. These fragments are sequenced to analyze genomic
regions for protein-DNA interactions. Sequencing refers to the method which is used to de-
termine the order of nucleotides in a DNA fragment. One of the powerful tools to sequence
DNA fragments is Next generation sequencing (NGS). ChIP combined with NGS is called
ChIP-Seq. Depending on the NGS technology being used, one limitation is that the length of
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the DNA fragment which can be sequenced (determine the order of nucleotides) varies from
35-700 bases [17] and human DNA is approximately 3 billion bases long. So to overcome
this limitation DNA is broken into smaller fragments called DNA library and only the ends
of fragment are sequenced using NGS [18]. The sequenced ends of fragments are called
reads or tags. NGS is also referred to as massively parallel sequencing or High Throughput
Sequencing (HTS) as all the fragments are sequenced in parallel [19]. The output of NGS is
a dataset consisting of millions of reads representing the nucleotide sequence at the end of
DNA fragments.
The standard ChIP-Seq data analysis workflow consists of two separate stages performed
in tandem: (1) Read Mapping, i.e., mapping all ChIP and control sequencing reads to the ref-
erence genome; (2) Peak Calling, i.e., identifying statistically significant ChIP read enriched
regions on the genome, referred to as peaks, based on the read density profile of the ChIP
and control mapped reads (Figure 1.4, left panel). The goal of read mapping is to align the
set of reads to a reference genome. A reference genome is a standard representative genome
of a species assembled by scientists. This step is called read alignment or mapping and the
computational tools to perform the task of mapping are called read aligners or read mappers.
Read mapping is computationally the most expensive stage in the data analysis pipeline.
The methods to perform the task of peak calling are called peak callers. Peak callers use
the output of read mapping to identify the genomic regions of TF-DNA interactions and hi-
stone modifications. In recent years, various read mapping and peak calling tools have been
developed, e.g., [20, 21, 22, 23, 24, 25, 26, 27, 28].
Different combinations of read mappers and peak callers have been used within the stan-
dard workflow. Despite the advancements in efficiency of read mappers and peak callers, the
standard tandem workflow has some major inherent drawbacks:
1. In ChIP the majority of the precipitated DNA fragments are the so-called background
reads, i.e., they do not originate from TF-DNA interaction sites of interest [29, 11].
However, in the first stage of the standard workflow, all reads are mapped to the
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Figure 1.4: The schematic diagram shows the standard workflow (left panel) and Map2Peak
workflow (right panel) for ChIP-Seq data analysis.
genome irrespective of whether they are background or true signal. Therefore, the
read mapper spends the majority of its computational time on mapping reads that have
no role in forming the true peaks.
2. Existence of background reads results in false positives during peak calling [11]. To
alleviate this issue, an additional so-called control read dataset (e.g., obtained from a
second ChIP-Seq assay done on the same sample using a control antibody) is mapped
to the genome to capture the background density profile, which is then used to offset
the background at the peak calling stage. In the standard workflow, control reads are
mapped to the whole genome. This is while eventually only the control read cover-
age information in the ChIP read-enriched genomic regions are needed, i.e, the effort
spent on aligning the control reads which do not map to the ChIP read enriched is
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unnecessary.
3. In the standard workflow, reads that align to more than one location on the genome,
referred to as multi-mappable reads, are often discarded at the read mapping stage to
avoid false positive peaks. A side effect of this is the reduced power of the standard
workflow to identify true peaks in the repeat elements of the genome, as reads originat-
ing from these elements are mostly multi-mappable. However, repeat elements such as
transposable elements and segmental duplications play critical roles in transcriptional
regulatory networks [30, 31, 32, 33, 34], hence identifying TF-DNA interaction sites
in repeat elements is important.
One possible solution to this issue is using software tools that resolve the location of
multi-mappable reads before peak calling, e.g., [35, 36, 37, 38, 39]. The input to these
tools is a mapped read dataset which contains multiple candidate locations for each
multi-mappable read. These tools resolve the location of each multi-mappable read by
calculating the probability that the read originates from each candidate location based
on the read density information around the candidate location. If used, these tools add
a significant computational burden to the standard workflow as they are computation-
ally very expensive. They also often have high false positive rates [39]. In addition,
the majority of their effort in the context of our application will again be focused on
resolving the locations of background reads.
We introduce Map2Peak, a novel tool aimed at mitigating the aforementioned drawbacks.
Map2Peak receives ChIP-Seq and control unmapped read dataset as the input and presents
the peaks as the outputs but it is in average twice faster than the standard tandem workflow
while it is comparable in accuracy. Map2Peak is designed based on the fact that reads from
true TF-DNA interaction sites are more likely to originate from genomic regions with higher
ChIP read density than those with lower ChIP read density. Contrary to the standard work-
flow, Map2Peak intertwines partial read mappings, statistical modeling to filter the genome,
and peak calling in a five-phase algorithm (Figure 1.4, right panel).
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Unlike the standard workflow, Map2Peak starts by mapping just a percentage of all ChIP
reads in its Phase 1 until a saturation criteria is satisfied. Saturation occurs when the rate
of increase in the number of distinct mapped read clusters on the genome in terms of the
number of mapped reads falls below a set threshold (we have noticed that in most datasets
this happens when around one third of the reads have been mapped (Table 4.3)). Once
saturation is reached, read mapping is paused and the data of the mapped ChIP-Seq reads is
passed to Phase 2.
In Phase 2, first, the fragment length (d) is estimated for the single-end datasets. Then
the genome is binned into equal-size (e.g., 50bp) bins and the fragment count in the bins is
modeled as the mixture of two Poisson distributions representing low ChIP read density re-
gions and high ChIP read density regions, i.e., ChIP read enriched regions. An Expectation-
Maximization (E-M) algorithm is implemented to classify bins into low ChIP read density
regions and ChIP read enriched regions. The ChIP read enriched regions are then stitched
together to form a DNA string much shorter than the original genome (1-10% of the original
genome length (Table 4.3)), which we refer to as the pseudo-genome. The low read density
regions along with all the reads which were mapped on them in Phase 1 are discarded.
In Phase 3, the remaining unmapped ChIP reads are mapped but not to the original
genome but to the (much shorter) pseudo-genome. This mapping to the pseudo-genome
is exact, which results in linear mapping time, i.e., (O(readlength)) [40, 22], and hence
reads which do not map to the pseudo-genome exactly are discarded in linear time. As the
majority of background reads do not align to the pseudo-genome, they are discarded with
substantial speed. Our computational results on several datasets show that using exact map-
ping in Phase 3 does not significantly affect the peak calling results. As we will report, we
were able to capture majority of the standard workflow peaks (Figure 4.1), and almost all
the peaks which were missed compared to the standard workflow were at the lowest tail of
statistical significance (Figure 4.2 and 4.3). There are two reasons that exact mapping works
well in Phase 3: First, we eliminate the possibility that a read that can be exactly mapped
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to the discarded part of the genome, gets mapped to some location on the pseudo-genome
inexactly. Second, even if peaks are at locations which contain genetic variations, e.g. SNPs
and InDels, since mapping in Phase 1 is done with errors allowed, the ChIP read enriched
regions bearing these peaks will be present in the pseudo-genome and the reads which will
exactly map to the areas surrounding the genetic variations will form the peak which will be
later detected in Phase 5.
In Phase 4, Map2Peak maps the control dataset. First, a percentage (same as percentage
of ChIP-Seq reads mapped in Phase 1) of control reads are mapped on to the whole genome
with mismatches and then the remaining percentage of control reads are mapped on the
pseudo-genome with exact matching. Control dataset is mapped in this fashion so that we
have a same rule for read mapping for ChIP and control dataset and to achieve correct scaling
between ChIP read coverage and control read coverage profiles during peak calling. Major
percentage of control dataset (Table 4.3) is forced to map on the pseudo-genome with exact
matching which reduces the computational burden of mapping control reads on the whole
genome. The intuition behind mapping majority of control reads to pseudo-genome is that
the peaks will be called (in Phase 5) from ChIP read enriched regions, i.e., pseudo-genome
and hence we want to control false positive peaks on pseudo-genome.
In Phase 5, Map2Peak uses the data of all the ChIP and control reads mapped on the
pseudo-genome to call peaks using a dynamic Poisson distribution. A dynamic Poisson
distribution is used to accommodate for the local bias in ChIP-Seq datasets [27]. The peak
locations were translated back to the original genome coordinates.
Map2Peak significantly mitigates all the aforementioned drawbacks of the standard
workflow. It speeds up mapping of the ChIP reads in Phase 3 and majority of control reads
in Phase 4 benefiting from the fact that alignment is being done exactly to a much smaller
smartly selected pseudo-genome of ChIP read enriched regions. Therefore, Map2Peak saves
significant computational time in Phase 3 and 4. Furthermore, exact mapping in Phase 3 does
not lead to missing peaks or getting smaller summit pileups. Moreover, Map2Peak does not
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discard multi-mappable reads as it is able to implicitly resolve their location if they happen
to map to ChIP read enriched regions uniquely.
We evaluate the performance of Map2Peak on ten ENCODE [41] ChIP-Seq datasets and
compared it to standard workflow. In standard workflow, we have used Bowtie [22] for read
mapping and MACS2 [27] for peak calling. The parameters used for read mapping in this
study (Section 4.2) are in consonance with the parameters used in [42]. Our results show
that approximately 90% of the background reads (in Phase 3) did not map on the pseudo-
genome selected by Map2Peak, and as mentioned, verifying whether a read maps onto the
pseudo-genome exactly occurs in linear time [22, 40]. As a result, Map2Peak is in average
about two times faster than the standard workflow while it is able to capture between 88%
to 96% of the peaks called by the standard workflow and some novel peaks which were not
detected by the standard workflow. We showed that these novel peaks share similar motif
with the peaks identified by standard workflow and observe that the percentage of novel
peaks overlapping with repeat elements of genome is equal or higher than the percentage
of non-novel peaks overlapping with repeat elements of the genome (Figure 4.8 and 4.9).
Although Map2Peak does not resolve the location of all multi-mappable reads but does so
for those which are more likely to form a peak, and hence, achieves the goal of existing
multi-mappability resolving tools.
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2. NECESSARY BACKGROUND
As mentioned earlier, genome-wide profiling of TF-DNA interactions and chromatin
modifications are important to understand transcriptional regulation [9]. During transcrip-
tion, the DNA region should become accessible for a TF to bind. This complex process
is coordinated by chromatin modifications and transcription factors. TFs can act as gene
activators or repressors [15]. TFs typically bind to a specific DNA sequence to regulate tran-
scription [43]. These specific DNA sequences are called motifs. Studies have shown that the
interactions between DNA and proteins are highly complex [44] and there is a need to map
genome-wide interactions for better understanding of cell developmental stages and disease
states [13]. The technique to study genome-wide protein-DNA interactions is Chromatin
Immunoprecipitation (ChIP) followed by Next generation sequencing (NGS).
In this section, relevant biological and chemical concepts are explained along with a
review on data analysis methods available in the literature to the extent that the reader can
understand the scope of the research and the results.
2.1 DNA Packaging: Chromatin
As earlier mentioned in section 1, DNA is the hereditary material in living organisms.
DNA is stored inside the cell nucleus in the form of chromatin and the knowledge of chro-
matin is important for understanding the mechanism of transcription regulation. Human
DNA consists of 3 billion base pairs and have two sets of DNA one from each parent. So, in
total in a cell there are 6 billion base pairs (Figure 2.1). Each base pair is 0.34 nanometers
long, hence each cell will have around 2 meters of DNA. The average diameter of nucleus
is approximately 6 micrometers. Hence, the packaging is highly intricate and complex. The
function of chromatin is to efficiently store DNA inside the nucleus. DNA is wrapped around
eight histone proteins to form nucleosome and the resulting DNA-protein complex is called
chromatin. Histones are a family of positively charged proteins and each nucleosome con-
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tains two units made up of histones H2A, H2B, H3 and H4. DNA is negatively charged
which enables DNA to wrap tightly around histones [4].
It is interesting to note that the part of the DNA which is wrapped around histones is in-
accessible. Hence, during transcription chromatin has to reconfigure its packaging to make
genes available for transcription. This complex process of reconfiguring DNA is coordi-
nated by histone modifications, TF-DNA interactions and chromatin remodeling activities.
Chromatin Immunoprecipitation (ChIP) is the chemical technique used to study this com-
plex process. This technique allows to map changes occurring in chromatin due to TF-DNA
interactions and histone modifications on genome-wide scale.
Figure 2.1: DNA is tightly wound around histones. Reprinted with permission from [4].
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2.2 Chromatin Immunoprecipitation (ChIP)
Chromatin Immunoprecipitation is a powerful DNA fragment library preparation tech-
nique used to understand protein-DNA interactions. In a ChIP experiment (Figure 2.2),
DNA-binding protein (TF or modified histones) are crosslinked using formaldehyde, a re-
versible crosslinking agent. This crosslinking preserves the protein-DNA interactions. Then
the chromatin is fragmented using sonication or enzymatic digestion. In case of histone mod-
ifications, Micrococal Nuclease (MNase) is used. Then the fragmented chromatin undergoes
immunoprecipitation using antibody specific to protein or histones of interest [9].
Figure 2.2: Process flow of ChIP. Reprinted with permission from [5].
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Finally the crosslinks are reversed and the selected DNA fragments are sequenced using
NGS platforms.
2.3 Next Generation Sequencing
Next Generation Sequencing (NGS), also known as High Throughput Sequencing (HTS)
is a DNA sequencing technology which has had a major impact on genomic research. NGS
platforms sequence millions of small DNA fragments in parallel (Figure 2.4). In 2003, the
technology used to complete sequencing of human genome, i.e., Human Genome Project
(HGP) was based on automated Sanger sequencing. Automated Sanger sequencing is con-
sidered as first generation technology. The completion of HGP revealed the need for more
advanced DNA sequencing technologies which led to the development of NGS. Since 2003,
major advancements in DNA sequencing has led to decreased cost of sequencing which has
generated huge amount of genomic data (Figure 2.3) [6]. Some of the commercial NGS
technologies are Illumina sequencing, Roche 454 sequencing, ION torrent sequencing, and
SOLiD sequencing. The next generation sequencing technologies have been reviewed in
articles [17, 19, 45, 46]. NGS technology has been applied for gene expression analysis,
structural variation detection (structural variation refers to insertion, deletion or inversion
in DNA sequence), protein-DNA interactions, de novo DNA sequence assembly and many
more.
Illumina NGS [28] uses library of DNA fragments as input, ChIP library in this research.
First, the ends of these fragments are ligated by synthetic adapters (Figure 2.4). The double
stranded fragments are denatured. These fragments attach to a solid surface, a flow cell,
which contain oligos complementary to the adapter sequences attached to fragment ends.
Then fragments attached on the solid surface are amplified (cluster formation) to emit suffi-
cient signal for each DNA sequencing reaction, the signal is used to determine a nucleotide
of the fragment, this step is called base call [19].
The DNA sequencing reaction/ cycle consists of three steps;
1. Nucleotide addition; in each sequencing cycle all four fluorescently labeled deoxy-
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Figure 2.3: Cost per genome. Reprinted with permission from [6].
ribonucleotide triphosphates (dNTPs) are added on to flow cell. These dNTPs contains
a terminator (blocking group) which allows for addition of only one nucleotide on each
fragment in a sequencing reaction. The terminator contains the fluorescent label.
2. Signal detection or base call; following the addition of dNTPs an image of flow cell
is scanned to determine which nucleotide (A, C, G, or T) was incorporated on each
fragment (cluster). This way millions of fragments (clusters) present on the flow cell
are sequenced parallel.
3. Wash step; after signal detection is performed the terminator group is removed.
This sequencing reaction is repeated several number of times. The number of times
sequencing reaction is repeated is restricted by signal quality during each cycle. The signal
quality deteriorates after each DNA sequencing reaction cycle, which limits the length of the
part of the fragment that can be sequenced. During each sequencing reaction along with the
base call the quality of the base call is also reported. Quality is defined in terms of “Phred”
score which is, Q = − log10 p, where p is the base calling error probability [47]. The rate
of signal deterioration differs across different NGS technologies. The part of the fragment
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Figure 2.4: Schematic of Illumina genome analyzer sequencing process. Reprinted with
permission from [7].
which is sequenced is called a read or a tag.
The output of sequencer in this research would be a ChIP-Seq dataset. A typical ChIP-
Seq dataset is the standardized “FASTQ” format [8].
In a “FASTQ” file, information about each read is written in four lines (Figure 2.5). The
first line is a read identifier starting with ’@’ containing sequence name and description, the
second line contains the sequence, the third line is again an identifier starting with ’+’ and the
last line contains the quality score for each base in the sequence. The quality score for each
nucleotide in “FASTQ” file is the ASCII representation of Q. The data which is generated
by ChIP followed by sequencing is referred to as ChIP-Seq dataset. In the next section, we
present the standard worklflow for ChIP-Seq data analysis.
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Figure 2.5: “FASTQ” format of a read. Reprinted with permission from [8].
2.4 Standard ChIP-Seq analysis
The current ChIP-Seq data analysis pipeline consists of different steps (Figure 2.6). Each
step employs different computational and statistical methods for analysis. The first step in the
pipeline is mapping ChIP and control reads on to genome using read mappers/aligners. After
alignment, peak callers are used to identify genomic regions where protein-DNA interactions
occur. Finally, biologically meaningful conclusions are made about identified protein-DNA
interaction regions using motif analysis, peak annotation analysis.
2.4.1 Read Mapping
As mentioned earlier, read is a short nucleotide sequence consisting of A, C, G and T
bases. The goal of read mappers is to align a read to a reference genome. A reference
genome is a standard representative genome of a species assembled by scientists.
There are various publicly available read mappers/aligners. The two main methods im-
plemented in aligners are:
1. Filtering: Filtering is the method to narrow down the search space i.e. instead of
searching on the whole genome, only a small portion of genome is considered. In
filtering, large portions of reference genome are filtered out as it is guaranteed that
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Figure 2.6: Standard workflow for ChIP-Seq data analysis
the read will not align in those regions. The small selected portion of DNA contain
a substring of read called seed [48] and the filtered out DNA do not contain the seed.
Finally, aligners try to map the read on the selected genome. Hashing combined with
pigeonhole principle [49] or q-gram filter is one of the filtering techniques.
2. Indexing: Indexing is a technique in which the reference genome is represented in a
different format called index. The advantage of searching on index is that read aligners
do not need to scan the whole DNA to map the read, therefore the search is fast. The
indices are implemented using suffix array [50], enhanced suffix array [51] and FM-
Index [40]. FM-index is based on Burrow Wheeler Transform (BWT) data structure
which was developed for string compression [48]. FM-index and enhanced suffix array
perform read search in reference genome in linear time with respect to the length of
the read [48].
It is important to note that the reported alignment location is not guaranteed to be correct
because of the presence of repetitive regions in reference genome, presence of sequencing
errors and difference between the sequenced genome and reference genome. To account for
sequencing errors, Single Nucleotide Polymorphisms (SNPs) and structural variation while
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read mapping, read mappers typically allow few mismatches during read alignment. SNPs
represents a difference in a single nucleotide which naturally occurs at a specific position
on a sample’s genome compared to a reference genome. A mismatch is a single nucleotide
substitution in the read.
Aligners report the alignment for sequencing dataset in a standard SAM (Sequence
Alignment/Map format) format. For each read, SAM file contains information about map-
ping position, DNA strand (Watson or Crick) on which reads maps to, mapping quality and
other alignment information. Some of the popular read aligners are bowtie [22], BWA [23],
SOAP [52], etc. The next step in ChIP-Seq data analysis is peak calling.
2.4.2 Peak calling
The goal of peak calling is to identify genomic regions of protein-DNA interactions and
histone modifications. It should be noted that during sequencing only 5′ ends of fragments
are sequenced and hence around protein-DNA interaction sites, reads will map to either left
or right of protein binding site (Figure 2.7). One of the DNA strand is referred as Watson
and other strand is referred as Crick. Watson strand is also called positive or forward strand
and Crick strand is called negative or reverse strand. A read mapped on Watson strand will
map on the left side of TF-DNA interaction or histone modification site and read mapped on
Crick stand will map on the right side of the TF-DNA interaction or histone modifications
site. After the reads are mapped a signal profile is generated using the mapping information
of ChIP-Seq dataset. A signal profile is built using the count data, i.e., number of mapped
reads at each genomic location. In a transcription factor experiment, a bimodal pattern in the
signal profile is observed around a TF binding site (Figure 2.7). A combined signal profile
is generated by extending the reads in 5′ to 3′ direction. The reads are extended equal to
the estimated fragment length (Recall that during sequencing only the ends of fragments
are sequenced, hence fragment length has to be estimated). The combined signal profile
is generated using the fragment count, i.e., number of mapped fragments at each genomic
location (Figure 2.7). Due to the presence of reads contributing to background noise in
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ChIP-Seq dataset the problem of peak calling is analogous to signal over noise detection.
Figure 2.7: Strand-specific read density profile at an enriched site. Reprinted with permission
from [9].
Before we proceed to discuss the peak calling methods on the signal profile, key consid-
erations in ChIP-Seq data analysis are:
• In an ideal ChIP-Seq experiment all the reads should come from regions of protein-
DNA interactions [53]. But in a ChIP experiment due to the occurrence of non-specific
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binding of protein and ChIP antibody, variability in chromatin accessibility and struc-
ture, GC-content bias [54, 55, 56] the generated reads do not always correspond to
TF-DNA interactions or histone modifications and contribute to background noise in
ChIP-Seq datasets. It was shown that this background noise is non-random [57, 58].
In order to estimate non-random distribution of background noise, peak callers use
control sequencing data. This data is also called as negative control. There are two
methods to generate control sequencing libraries [29];
– Input DNA is generated from DNA which is crosslinked and sonicated. The
experiment is performed under same condition as experimental sample.
– IgG/mock-ChIP which is generated using a nonspecific antibody which will not
bind to any specific protein. The antibody used is immunoglobulin G, IgG.
These libraries are sequenced to generate control datasets. The control datasets rep-
resent the noise present in the corresponding ChIP-Seq datasets. The experiment in
which control is not available and only ChIP-Seq dataset is available are called one
sample experiment and when both the datasets are available the experiment is called a
two sample experiment. Peak callers utilize control dataset to increase the sensitivity
and specificity of peak detection.
• Depending on the ChIP dataset (transcription factors or histones) under analysis the
parameters for peak calling algorithm should be adjusted. Peaks are categorized [11,
10, 59] (Figure 2.8) as follows:
– Sharp/punctate peaks: These peaks span around few hundred base pair and gen-
erate localized ChIP-Seq peaks. These peaks are generated by most sequence-
specific transcription factors. Example of such peaks profile are NRSF and CTCF
[60] transcription factors.
– Broad peaks: These peaks span around hundreds of kilo base pairs. Example of
such peaks profile are histone marks, H3K9me3, H3K36me3 [61] and chromatin
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domain signatures.
– Mixed peaks: These peaks contain both sharp and broad peaks. Example for such
peaks profile is RNA polymerase II [59, 62].
Figure 2.8: Signal profile. Reprinted with permission from [10].
These different categories have distinct features and peak callers take advantage of
these features to identify true peaks optimally. Most of the peak callers are developed
for sharp/punctate peaks [11].
The first step in locating TF binding sites is to identify genomic regions with high ChIP
read/tag density, such regions are called enriched regions. There are various methods to
identify enriched regions; one of the method is to identify regions where extended reads, i.e.,
fragment, overlap [63, 20, 25]. Another method is to bin the whole DNA into fixed windows
[26, 64, 65, 24, 27, 66, 21] and calculate the number of tags falling into each bin and identify
enriched regions. Some methods search for bimodal tag alignment pattern (Figure 2.7) on
negative and positive strand to identify protein binding sites or this method can be used in
post filtering process in addition to the other methods mentioned. This bimodal pattern is
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predominant around transcription factor binding sites. SISSRs [65] uses the sign change of
difference between number of forward and reverse strand aligned reads in a window to iden-
tify protein binding site, CisGenome [21] uses peaks of bimodal pattern to identify protein
binding sites boundaries. MACS [27] uses bimodal pattern to identify fragment length and
extends reads in 5′ to 3′ direction equal to the estimated length of fragment. Then MACS
uses merged fragment density of Watson and Crick strand to identify protein-DNA interac-
tion sites. There are methods which use peak shape information. PICS [28] jointly models
distribution of peaks on forward and reverse strand (bimodal pattern) as two t-distributions
with shifted centers. GPS [67] uses empirical distribution to characterize peak shape. T-PIC
[68] calculates a statistic to describe a peak shape information.
In case of histone modifications, the peaks are diffuse compared to peaks in transcription
factor datasets. The enriched regions in histone modifications are referred to as domains [59].
In case of histone modifications bimodal pattern in signal profile may be absent. Some of
the statistical methods available to identify broad regions of interest are SICER [69], CCAT
[70], ZINBA [60], and RSEG [71]. Other methods such as MACS [27], SPP [64] can be
used for broad peak detection using different parameter settings.
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Figure 2.9: ChIP-Seq signal vs background noise. Reprinted with permission from [11].
Next step for peak callers is to identify genomic regions with significant ChIP read en-
richment over background noise. In case of one sample ChIP experiment the background
noise can be modeled as Poisson distribution [65] or negative binomial distribution [26, 21].
The parameters for these distribution is estimated using regions with low tag/read distribu-
tion. It was shown that these backgrounds models are not able to capture [72] the background
noise in ChIP-Seq data effectively and the distribution of noise is non-random [57, 58].
Hence, the need for control datasets.
The distribution of reads/tags in control dataset around the probable protein binding site
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is utilized to calculate the significance of the ChIP enriched genomic region. Peak callers use
control dataset in different ways to identify significance of read enriched genomic regions
(Figure 2.9). One method is to identify the fold enrichment of ChIP reads over control
reads in the probable binding region. Control dataset is also used to identify empirical false
discovery rate (FDR) by finding the number of peaks in control data and using ChIP data as
control.
Peak callers use different statistical models to associate statistical significance such as
p-value, q-value with the called peaks.
2.4.3 Downstream analysis
After peak calling is performed we need to associate peak regions to functionally relevant
genomic regions, such as transcription start sites (TSS), introns, promoters, enhancers, etc.
This downstream process is called Peak annotation. There are various publicly available
tools to perform peak annotation for example, ChIPpeakAnno [73], DAVID [74], GREAT
[75] and GSEA [76].
Motif discovery analysis is used to find the protein-binding motif in ChIP-Seq peaks.
Motif is a small sequence of DNA where a specific transcription factor binds (Figure 2.10).
Motif analysis is also used to benchmark peak calling tools using known motif of the ChIP-
ed protein. If motif is not known, presence of consensus motif can also be used to benchmark
peak calling tools. There are various publicly available tools to perform motif discovery anal-
ysis. Some of the tools are MEME [77], peak-motifs [12], etc. The motifs are represented as
sequence logo’s- a graphical representation of motif (Figure 2.10).
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Figure 2.10: Sequence logos for binding motifs of Met4p and Met31p transcription factors.
Reprinted with permission from [12].
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3. ALGORITHM
Contrary to standard workflow Map2Peak performs the overall workflow in 5 phases and
combines the process of read alignment and peak calling. During Phase 1, ChIP reads are
mapped on to the whole genome, the reads are mapped until the read island saturation is
achieved. As the reads get mapped, they start to form read clusters and these read clusters
are referred to as read islands. As the number of aligned reads increase the rate of increase of
read island decreases. Once this read island saturation is achieved, read mapping is paused
and the mapping information is passed on to Phase 2. In Phase 2, the fragment length is esti-
mated and then fragment count is calculated in 50 bp bins across genome. Fragment count is
the number of fragment overlapping with a bin. Fragment count is then modeled as a mixture
of two poisson distributions representing “zero to low” ChIP read enriched regions and ChIP
read enriched genomic regions. Expectation-Maximization (E-M) algorithm is implemented
to identify enriched genomic regions. These enriched genomic regions are stitched together
to form a smaller genome i.e. pseudo-genome and the rest of the genomic regions (“zero to
low ChIP enriched regions) are discarded and the pseudo-genome is indexed using bowtie
indexer. In Phase 3, the remaining ChIP reads are mapped to the pseudo-genome with no
mismatches. We proceed to Phase 4, in which control reads are aligned. First a percentage
of control reads are aligned on to the whole genome with mismatches and the remaining
percentage of control reads are mapped on to the pseudo-genome with no mismatches. The
percentage of control reads mapped to the whole genome is same as the percentage of ChIP
reads mapped in Phase 1. Control reads are mapped in this fashion so as to have the same
mapping rule for both ChIP and control reads. Finally in Phase 5, after all the ChIP and
control reads were aligned, peak calling is performed to identify genomic regions containing
TF-DNA interactions. Algorithm 1 shows the overall workflow of Map2Peak.
The advantage of this methodology is that in Phase 3 (ChIP reads) and in Phase 5 (major-
ity of control reads) do not map to pseudo genome and therefore are discarded from further
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Algorithm 1 Map2Peak’s overall algorithm
Require: Ri, i = 1 to N, N are number of ChIP-Seq reads, indexed reference genome
1: Phase3 = false, Phase2Check=false, control=true(if control file available)
2: for i = 1 to N do
3: if Phase3 = false then
4: align read Ri on whole genome
5: store mapping information
6: else
7: align read Ri on pseudo genome with 0 mismatches
8: store mapping information
9: end if
10: if i mod J = 0 and Phase3=false then
11: if increase in read islands with J < Threshold(T ) then
12: Phase2Chk←true
13: x← i
M
; percentage of ChIP reads mapped in phase 1
14: end if
15: end if
16: if Phase2Chk=true then
17: Phase3←true
18: estimate fragment length
19: bin genome into 50bp window and calculate number of fragments in each bin. Let
fragment count data be D.
20: model distribution of data D as a mixture of two Poisson distributions, one for low
read enriched genomic regions and another for enriched genomic regions.
21: classify each 50bp bin as background or probable protein binding bin using EM.
22: select bins classified as enriched genomic regions; pseudo genome
23: create bowtie index for pseudo genome (use bowtie indexer)
24: end if
25: end for
26: if control=true then
Require: Rj , j = 1 to M, M are number of Control reads, indexed reference genome
27: for j = 1 to M do
28: if j < Mx then
29: align read Rj on whole genome
30: store mapping information
31: else
32: align read Rj on pseudo genome with 0 mismatches
33: store mapping information
34: end if
35: end for
36: end if
37: call peaks using ChIP and control mapping information (step 5, 8, 30 and 33); (imple-
mented MACS2 heuristics)
Ensure: Alignment file, Peak List
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analysis. Also, as the ChIP reads are mapped on to pseudo genome, some of the ChIP reads
which are multi-mappable on the whole genome became uniquely mappable on the pseudo-
genome. This happens because some of the repeat regions are discarded during Phase 2. The
intuition behind Map2Peak approach is that in a ChIP-Seq experiment for TF-DNA inter-
action a true/signal read (multi-mappable or uniquely mappable) has higher probability to
originate from genomic regions with higher ChIP read density than genomic regions which
have low read density. Also, control reads are required to control false positives in higher
ChIP read density regions and hence need to be mapped only to higher ChIP read density
regions. Hence, we map majority of control reads on to pseudo-genome.
3.1 Phase 1: Map as many reads as needed until read island saturation is reached
In this Phase, the unmapped ChIP reads are mapped on to whole genome. As the reads
get mapped, their mapping information is stored in two separate bit-array data structures,
one for each strand (watson and crick) of the genome. A bit is set to 1 when the 5′ end of a
mapped read maps to the genomic coordinate corresponding to that bit, i.e.,
ChIPMapj[i] =

1, if 5′ end of some read align at location i on strand j
0, if no read aligns at location i
where j = {watson, crick}, i = 1, ..., L, and L is the length of genome. This is an efficient
method of storing the mapping information.
After mapping every J (a parameter to Map2Peak) number of ChIP reads, the increase
in number of read islands is calculated. A read island is defined as a segment of the DNA,
where the mapped reads are no more than the fragment length nucleotides apart. So, a read
R when aligned may map to an existing island or form a new island by itself. The fragment
length used is an upper bound value of 600bp [78]. The fragment length for the ChIP library
will be estimated in the next phase. When the increase in number of read islands falls below
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a set threshold T (a parameter to Map2Peak), island saturation is attained. At this point,
read mapping is paused and the mapped read information is passed to Phase 2. Algorithm 2
shows Phase 1 of Map2Peak. Let the percentage of ChIP reads aligned in phase 1 be x%.
Algorithm 2 Map2Peak: Phase 1
Require: Ri, i = 1 to N, N are number of ChIP-Seq reads, indexed reference genome
1: J (number of ChIP reads), T (threshold), read island=0
2: for i = 1 to N do
3: align read Ri on whole genome
4: store mapping information in ChIPMap array
5: if read Ri makes a new island then
6: read island← read island+1
7: end if
8: if i mod J = 0 then
9: if increase in read islands with J < Threshold(T ) then
10: x← i
M
; x percentage of ChIP reads mapped in phase 1
11: Phase1reads=i and break out of for loop
12: end if
13: end if
14: end for
Ensure: Call Phase 2 algorithm (ChIPMap array)
3.2 Phase 2: Select candidate enriched regions using Expectation-Maximization
The first step in this phase is to estimate the fragment length for the ChIP library. To estimate
fragment length, signal profile (read pileup at each genomic coordinate) is constructed for
Watson and Crick strand using Phase 1 mapping information. Signal profile is generated
by extending the read alignments in 5′ to 3′ direction. The signal profile for Crick strand
lags signal profile for Watson strand. To estimate the fragment length, cross-correlation is
calculated to measure the similarity between signal profiles. The read signal profile for Crick
strand is shifted in 5′ to 3′ direction and at each value of shift, cross-correlation is calculated.
The shift at which cross-correlation is maximized, is the optimal shift size [64, 42]. Optimal
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shift size is the estimated fragment length. The optimal shift size is forced to be above twice
the read length to avoid low fragment length value. Some ChIP libraries have optimal shift
size equal to read length which is an indication of problems with ChIP library and hence
a need to avoid low fragment length values. Algorithm 3 shows Map2peak’s procedure to
estimate fragment length.
Algorithm 3 Map2Peak: Phase 2, fragment length estimation
Require: ChIPMap array from phase 1, Read length
1: build read signal profile for watson strand using ChIPMapwatson
2: build read signal profile for crick strand using ChIPMapcrick
3: for i = 2∗Read length to 600 do
4: shift crick strand i units in 5′ to 3′ direction
5: calculate cross-correlation between watson strand and shifted crick strand
6: store cross-correlation for shift i
7: end for
8: return i at which cross-correlation is maximum
After fragment length estimation, each mapped read is extended to fragment length size
in 5′ to 3′ direction and fragment count is calculated in 50bp bins across the genome. Frag-
ment count is the number of fragments covering a bin with any overlap.
The distribution of fragment count, x, in each bin is then modeled as a mixture of two
Poisson components. Component 1 represents fragment count in “zero to low” ChIP read
bins and component 2 represents ChIP enriched bins. The distribution of x is defined as
f(x|θ) =
2∑
k=1
pikλk
xe−λk
x!
,
where k = 1 (low ChIP read enriched) or 2 (high ChIP read enriched), identifies the two
components of the Poisson mixture. Let N be the number of bins. The joint likelihood of
~x = {x1, x2, ..., xN} assuming i.i.d is defined as
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L(~θ|~x) = f(~x|~θ) (3.1)
=
N∏
i=1
f(xi|θ) (3.2)
=
N∏
i=1
2∑
k=1
pikλk
xie−λk
xi!
(3.3)
where ~θ = {pi1, pi2, λ1, λ2}
pi1, pi2 are mixing probabilities, i.e, proportion of bins from component 1 and component 2
respectively. pi1 = p(k = 1) and pi2 = p(k = 2) s.t.
2∑
k=1
pik = 1; 0 ≤ pik ≤ 1
and λ1, λ2 are the means of component 1 and 2, respectively.
The parameters ~θ are estimated by maximizing the log likelihood of 3.3, which is defined as
~ˆθ∗ = argmax
~θ
log(L(~θ|~x))
The direct maximization of 3.2 is difficult because of the summation of terms inside the
logarithm. The observed data is incomplete as we do not know which component the ob-
servations x1, x2, .., xN belong to, this missing information is the hidden/latent data. We use
Expectation-Maximization (E-M) [79] algorithm to estimate parameters ~θ∗ (for complete
details, see section 3.2.1):
Expectation step (iteration t). For a given parameter values compute the expected val-
ues of the latent variables. The expected value of latent variables is equal to membership
probabilities for k = 1, 2, and i = 1, . . . , N (for complete details, see section 3.2.1):
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p(k|x, ~θ(t)) =
pi
(t)
k λ
(t)
k
x
e
−λ(t)
k
x!∑K
i=1
pi
(t)
i λ
(t)
i
x
e−λ
(t)
i
x!
(3.4)
Maximization step (iteration t): Re-estimate the parameters using the current membership
probabilities (for complete details, see section 3.2.1):
λ
(t+1)
k =
∑N
i=1 xip(k|xi, ~θ(t))∑N
i=1 p(k|xi, ~θ(t))
(3.5)
pi
(t+1)
k =
∑N
i=1 p(k|xi, ~θ(t))
N
(3.6)
Algorithm 4 Map2Peak: Phase 2, E-M algorithm
Require: data D = ~x, ~θ = {pi1, ..., piK ;λ1, ..., λK}, convergence criteria C = (~θ < )
1: while convergence criteria C is satisfied do
2: Update Expectation (E-step) iteration t
3: p(k|x, ~θ(t)) =
pi
(t)
k
λ
(t)
k
x
e
−λ(t)
k
x!∑K
i=1
pi
(t)
i
λ
(t)
i
x
e
−λ(t)
i
x!
4: Maximize parameters (M-step) iteration t
5: λ
(t+1)
k =
∑N
i=1 xip(k|xi,~θ(t))∑N
i=1 p(k|xi,~θ(t))
6: pi
(t+1)
k =
∑N
i=1 p(k|xi,~θ(t))
N
7: end while
8: for i = 1 to N do
9: if p(k = 2|xi) >= emCutoff then
10: assign bin i to component-2 (pseudo-genome)
11: end if
12: end for
Iterate between expectation and maximization step until convergence. Algorithm 4 shows the
EM procedure. After E-M algorithm converges, we have membership probabilities p(k|x),
i.e., the probability that a bin with fragment count x belong to component k. Using these
membership probabilities, the fragment count cutoff xcutoff is calculated. xcutoff will be
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equal to the fragment count x for which p(k = 2|x) is closest to tcutoff , where tcutoff is the
probability above which we classify a bin as an ChIP enriched bin.
For every bin i, if fragment count xi ≥ xcutoff then bin i is assigned to component 2
(ChIP enriched regions) otherwise bin i is assigned to component 1 (“zero to low” ChIP
enriched regions). The bins representing component 2 are stitched together to form the
pseudo-genome. The pseudo-genome is indexed using bowtie indexer.
3.2.1 Mixture distribution of K Poissons
Given a set of n observations, ~x = {x1, x2, ..., xn}, from K Poisson distributions.
The mixture distribution of an observation x :
f(x|θ) =
K∑
k=1
pikλk
xe−λk
x!
The joint distribution of ~x = {x1, x2, ..., xN} assuming i.i.d is defined as:
f(~x|~θ) =
N∏
i=1
f(xi|θ)
=
N∏
i=1
K∑
k=1
pikλk
xie−λk
xi!
where ~θ = {pi1, ..., piK ;λ1, ..., λK} are the parameters for K Poisson distributions. K are
the number of components and pik are the mixing probabilities, i.e., proportion of bins from
component 1, 2...K respectively. s.t.,
K∑
1
pik = 1; 0 ≤ pik ≤ 1
and λ1, ..., λK are the means of component 1, ..., K respectively.
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So, the likelihood function for observation ~x = {x1, x2, ..., xN} will be;
L(~θ|~x) = f(~x|~θ)
=
N∏
i=1
f(xi|θ)
=
N∏
i=1
K∑
k=1
pikλk
xie−λk
xi!
and the log-likelihood will be;
log(L(~θ|~x)) =
N∑
i=1
log
K∑
k=1
pikλk
xie−λk
xi!
(3.7)
To estimate parameters ~θ, we require to maximize log(L(~θ|~x)),
~ˆθ∗ = argmax
~θ
log(L(~θ|~x))
3.2.1.1 Expectation-Maximization
The direct maximization of 3.7 is difficult because of the summation of terms inside the
logarithm. In order to estimate ~ˆθ∗ we use Expectation-Maximization (E-M) [79] algorithm.
We consider latent/hidden variable zik, which is defined as,
zik =

1, if xi (ith observation) comes from component k
0, otherwise
zi is a binary vector of length K. Assume that we knew zik ′s then the complete data likeli-
hood can be written as;
L(~θ|~x, ~z) =
N∏
i=1
K∏
k=1
(pikλkxie−λk
xi!
)zik
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and loglikelihood of complete data will be;
log(L(~θ|~x, ~z)) =
N∑
i=1
K∑
k=1
zik log
(pikλkxie−λk
xi!
)
(3.8)
But actually we do not know the values of zik ′s, so we will use EM algorithm.
E-step (at iteration t)
Compute Q(~θ, ~θ(k)), which is the expectation of the complete data loglikelihood, 3.8, with
respect to the conditional distribution of hidden variables conditioned on incomplete data
and current estimate of θ, i.e., θ(t)
Q(~θ, ~θ(t)) = E~z|~x,θ(t)
[ N∑
i=1
K∑
k=1
zik log
(pikλkxie−λk
xi!
)]
=
N∑
i=1
K∑
k=1
E[zik|~x, ~θ(t)] log
(pikλkxie−λk
xi!
)
E[zik|~θ(t), ~x] = p(zik = 1|~θ(t), ~x)
= p(k|xi, ~θ(t))
We call p(k|xi) as membership probabilities, i.e., observation xi belongs to component k.
Generally, the conditional probability of selecting a component k, given that we have obser-
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vation x,
p(k|x, ~θ(t)) = p(k, x|
~θ(t))
p(x|~θ(t))
=
p(k, x|~θ(t))∑K
i=1 p(i, x|~θ(t))
=
pi
(t)
k λ
(t)
k
x
e
−λ(t)
k
x!∑K
i=1
pi
(t)
i λ
(t)
i
x
e−λ
(t)
i
x!
where the joint probability of selecting component k and observing x from component k.
p(k, x|~θ(t)) = pi
(t)
k λ
(t)
k
x
e−λ
(t)
k
x!
To initiate E-M iterations, we have to assume parameters ~θ(1) = {pi1, ..., piK ;λ1, ..., λK}.
During E-step, we calculate the expectation that observation x belongs to component k,
k = {1, 2, ..., K} based on estimate, ~θ(t).
M-step (at iteration t)
During M-step, we improve the existing estimates, ~θ(t) by maximizing.
~θ(t+1) = argmax
~θ
Q(~θ, ~θ(t)) (3.9)
~θ(t+1) = E[log(L(~θ|~x, ~z))] =
N∑
i=1
K∑
k=1
E[zik|~x, ~θ(t)] log
(pikλkxie−λk
xi!
)
(3.10)
E[zik|~x, ~θ(t)] = p(k|xi, ~θ(t)) was estimated in E-step.
So, we maximize (3.9) to estimate ~θ and call, (3.10) G1
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~θ(t+1) = argmax
~θ
G1
Let’s estimate, λk,
∂G1
∂λk
=
N∑
i=1
p(k|xi, ~θ(t)) ∂
∂λk
log(
pikλk
xie−λk
xi!
) = 0
Solve (3.2.1.1),
∂G1
∂λk
=
N∑
i=1
p(k|xi, ~θ(t)) ∂
∂λk
log(
pikλk
xie−λk
xi!
)
=
N∑
i=1
p(k|xi, ~θ(t)) ∂
∂λk
[log(pik) + xi log(λk)− λk − log(xi! )]
=
N∑
i=1
p(k|xi, ~θ(t))[ xi
λk
− 1] = 0
=⇒ λ(t+1)k =
∑N
i=1 xip(k|xi, ~θ(t))∑N
i=1 p(k|xi, ~θ(t))
∂2G1
∂λ2k
= −
N∑
i=1
p(k|xi, ~θ(t)) xi
λ2k
≤ 0
Now let’s estimate, pi(t+1)k
we have a constraint on pik, i.e.,
∑K
k=1 pik = 1.
So, to estimate pik we will use lagrange multiplier µ and define G2 = G1 + µ(
∑K
k=1 pik − 1).
G2 =
N∑
i=1
K∑
k=1
(p(k|xi, ~θ(t)) log(pikλk
xie−λk
xi!
) + µ(
K∑
k=1
pik − 1)
∂G2
∂pik
= 0
38
Solve (3.2.1.1),
∂G2
∂pik
=
N∑
i=1
p(k|xi, ~θ(t)) ∂
∂pik
log(
pikλk
xie−λk
xi!
) + µ
∂
∂pik
(
K∑
k=1
pik − 1)
=
N∑
i=1
p(k|xi, ~θ(t)) ∂
∂pik
[log(pik) + xi log(λk)− λk − log(xi! )] + µ
=
∑N
i=1 p(k|xi, ~θ(t))
pik
+ µ = 0
=⇒ pi(t+1)k = −
∑N
i=1 p(k|xi, ~θ(t))
µ
and we know
N∑
i=1
pik = 1
So,
K∑
i=k
pik = −
∑N
i=1
∑K
k=1 p(k|xi, ~θ(t))
µ
= 1
=⇒ µ = −
N∑
i=1
K∑
k=1
p(k|xi, ~θ(t))
=⇒ µ = −N
Hence,
pi
(t+1)
k =
∑N
i=1 p(k|xi, ~θ(t))
N
∂2G2
∂pi2k
=
−∑Ni=1 p(k|xi, ~θ(t))
pi2k
≤ 0
Iterate between expectation and maximization step until ~θ converges.
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3.3 Phase 4: Map remaining reads on pseudo-genome
In this phase, read mapping is resumed for the remaining unmapped ((100−x)% of ChIP-
Seq dataset) ChIP reads but they are mapped to the pseudo-genome instead of the whole
genome. This mapping to the pseudo-genome is exact, which results in linear mapping time
for each read, i.e, O(readlength) and hence reads which do not map to the pseudo-genome
exactly are discarded as background reads in linear time. As pseudo-genome contains only
ChIP enriched genomic regions, the majority of reads do not align on the pseudo-genome.
Therefore, this phase brings computational speed to Map2Peak. Our computational results
on several datasets show that using exact mapping in Phase 3 does not significantly affect
the peak calling results. As we will report, we were able to capture majority of the stan-
dard workflow peaks, and almost all the peaks which were missed compared to the standard
workflow were at the lowest tail of statistical significance (Figure 4.2 and 4.3). The reasons
for the fact that exact mapping works well in Phase 3 were elaborated in Section 1. The
mapping information of this phase is is stored in ChIPMap array defined in Phase 1.
3.4 Phase 4: Map control reads
In this phase, control reads are mapped. A x% of control reads are mapped on to the
whole genome with mismatches and then the remaining (100 − x)% of control reads are
mapped on to the pseudo-genome with exact matching. The percentage of control reads
which are mapped on the whole genome is same as the percentage of ChIP reads which were
earlier mapped in Phase 1. Ideally we need to align control reads only on pseudo-genome
because peak calling will be performed only on pseudo-genome but during peak calling
we would also be scaling control and ChIP read coverage and hence we would need same
mapping rule for ChIP and control reads to get a correct scaling factor. Hence, we need to
map control reads in this fashion.
As the reads get mapped, their mapping information is stored in two separate bit-array
data structures, one for each strand (watson and crick) of the genome. A bit is set to 1 when
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the 5′ end of a mapped read maps to the genomic coordinate corresponding to that bit, i.e.,
ControlMapj[i] =

1, if 5′ end of some read align at location i on strand j
0, if no read aligns at location i
where j = {watson, crick}, i = 1, ..., L, and L is the length of genome. If the control
dataset is not provided then this phase is skipped.
Algorithm 5 Map2Peak: Phase 4, align control reads
Require: Rj , j = 1 to M, M are number of Control reads, indexed reference and pseudo
genome
1: for j = 1 to M do
2: if j < Mx then
3: align read Rj on whole genome
4: store mapping information
5: store mapping information in ControlMap array
6: else
7: align read Rj on pseudo genome with 0 mismatches
8: store mapping information
9: store mapping information in ControlMap array
10: end if
11: end for
Ensure: ControlMap array
41
3.5 Phase 5: Call peaks on pseudo-genome
Map2Peak peak calling is done on the pseudo-genome instead of the whole genome and
is based on MACS [27] heuristics. The pileup of fragments at every genomic coordinate is
calculated by extending each mapped read to the estimated fragment length size in 5′ to 3′
direction. The fragment count is modeled as a Poisson distribution. Every local maximum
(summit) of pileup is statistically tested for being a peak. Instead of using a uniform mean
for Poisson distribution, local background, λlocal is used to accommodate for the local bias
in ChIP-Seq dataset. There are different sources of local bias such as chromatin structure,
sequencing bias, DNA amplification, and genome copy number variation [80]. Local back-
ground is defined λlocal = max{λBG, λd, λ1K , λ10K}, where λBG is the mean fragment count
over the whole genome, and λd, λ1K and λ10K are the mean fragment count calculated in d,
1K and 10K base pair bins centered at the summit location in the control dataset, respec-
tively. If the control dataset is not available then λlocal = max{λBG, λ1K , λ10K}, where λBG
is the mean fragment count over the whole genome, and λ1K and λ10K are the mean fragment
count calculated in 5K and 10K base pair bins centered at the summit location in the ChIP
dataset, respectively. λlocal is used to calculate p-value for each local summit in the fragment
pileup and the summits which have p-value less than the user-defined p-value threshold (de-
fault 10−5) are called and reported. Along with the summit location, we also report the peak
width, summit height and the p-value for each reported peak.
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4. RESULTS
In this chapter, we evaluate the performance of Map2Peak. To evaluate Map2Peak we
have used 12 ChIP-Seq dataset, 10 single end datasets and 2 paired end dataset. PE datasets
were used to verify the ability of Map2Peak to correctly discard majority of background
reads. The remaining 10 SE datasets were first used to compare the computation time of
Map2Peak and standard workflow, then we quantitatively and qualitatively compare the num-
ber of peaks called by Map2Peak and standard workflow. Finally, we compare the ability of
Map2Peak to resolve multimappable reads and call peaks in repeat elements of genome and
prove that the novel peaks identified by Map2Peak are in fact legit peaks.
4.1 Datasets
To evaluate the performance of Map2Peak, we utilized twelve ChIP-Seq datasets (Table
4.1) All datasets were downloaded from ENCODE consortium [41] database. For consis-
tency with current NGS trends, we utilized the datasets which have longer read length. We
used 10 single end and 2 paired end ChIP-Seq datasets and their associated control datasets.
The SE datasets contain 5 datasets of 50 base pair read length and 5 datasets of 76 base pair
read length and the PE datasets used in this study have a read length 100 bp.
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4.2 Parameters used in this study for Map2Peak and standard workflow
4.2.1 Standard workflow parameter settings
In standard workflow, we have used Bowtie for read alignment and MACS2 for peak call-
ing. During read alignment of ChIP-Seq and control dataset we have used Bowtie 1 with
parameters -v 2 -m 1 -best -strata. These parameters map reads with at most 2
mismatches and discard reads which have more then one mapping location in best strata.
Stratum is based on mismatches, i.e., 0-mismatch strata, 1-mismatch strata, and so on. Dur-
ing peak calling we have passed ChIP and control alignment files to MACS2. During peak
calling, we have called peaks with statistical significance (p.value) of less than or equal to
10−5.
4.2.2 Map2Peak parameter settings
Map2peak uses Bowtie 1 as a read aligner and implements MACS2 heuristics during peak
calling. For fair comparison with standard workflow, Map2Peak uses same parameter set-
tings during read alignment and peak calling.
4.2.2.1 Phase 1: Mapping ChIP reads on whole genome
In Phase 1, during read alignment we have used parameters -v 2 -m 1 -best
-strata. These parameters maps reads with at most 2 mismatches and discards reads
which have more then one mapping location in best strata. Stratum is based on mis-
matches,i.e., 0-mismatch strata, 1-mismatch-strata, and so on.
4.2.2.2 Phase 2: Statistical model to select pseudo-genome
In Phase 2, we perform E-M algorithm. The parameter settings in the phase are the default
Map2Peak parameter values (refer section B.3).
4.2.2.3 Phase 3: Mapping ChIP reads on pseudo-genome
In Phase 3, during read alignment we have used parameters -v 0 -m 1 -best
-strata. These parameter settings are same as in Phase 1 except that we allow no mis-
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matches.
4.2.2.4 Phase 4: Mapping control reads
During Phase 4, control reads are mapped using Bowtie. For a percentage of control dataset,
the parameters used during read alignment are -v 2 -m 1 -best -strata and for
the remaining control reads we have used parameters, -v 0 -m 1 -best -strata.
The percentage of control reads which are mapped with parameters -v 2 -m 1 -best
-strata are same as the percentage of ChIP reads which are mapped with parameters -v
2 -m 1 -best -strata.
4.2.2.5 Phase 5: Peak calling
In Phase 5 peak calling is performed, we have called peaks with statistical significance
(p.value) of less than or equal to 10−5. As the parameter settings used during read alignment
and peak calling in standard workflow and Map2Peak are same, the comparison between
Map2Peak and standard workflow is fair.
4.3 Map2Peak correctly discards many background reads
In Phase 3 of Map2Peak, ChIP-Seq reads are exactly mapped on to a much smaller
pseudo-genome. Because of this stricter mapping criterion on a smaller genome (pseudo-
genome) many reads do not map to the pseudo-genome. To assess that the ChIP-Seq reads
which are discarded during this phase are true background reads, we artificially generated
ChIP-Seq datasets with reads classified as background (which do not form true peaks) reads
and signal (which form true peaks) reads. To generate such datasets, we utilized real 100-bp
Paired-End (PE) ChIP-Seq datasets. First, the PE ChIP and associated control reads were
mapped to the genome using bowtie and then the peak calling is performed using MACS2.
These peaks are used as representative of true peaks and were used to classify reads into
background and signal reads. Then, we generated Single End (SE) reads of read length 50
bps, 76bps from PE datasets by selecting first mate of the paired read and trimming it from
3′ end (Table 4.2). Each of these artificially generated SE datasets were aligned on the whole
46
genome. The reads which had their alignment location overlap with reference peak list were
labeled as signal reads and the reads which did not overlap with reference peak list were
labeled as background reads (Table 4.2). The artificially generated datasets were passed
to Map2Peak to generate pseudo-genome. Once the pseudo-genome is selected, for each
dataset the reads which were classified as signal and background reads were mapped exactly
(no mismatches) on the pseudo-genome. The mapping results are in Table 4.2. Ideally, we
would want background reads to not map on the pseudo-genome and map all the signal reads
on the pseudo-genome. In Table 4.2, we observe that for PKNOX1 dataset with read length
of 50nt, 90% of the background reads did not map and 87% of the signal reads map to the
pseudogenome. For PKNOX1 dataset with read length of 76nt, 91% of the background did
not map and 82% of the signal reads map on the pseudo-genome. In case of SIN3A dataset
with read length of 50nt, 89% of the background reads did not map and 76% of the signal
reads map to the pseudo-genome. For dataset with read of 76nt, 90% of the background reads
did not map and 71% of the signal reads map to the pseudo-genome. Another important point
to note here is that major portion of the artificially generated datasets consist of background
reads which is also true for majority of real ChIP-Seq datasets [29, 11].
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4.4 Map2Peak versus standard workflow
In this section, we compare the performance of Map2Peak with the standard workflow.
We begin by comparing the computation time to generate peak list from unmapped ChIP-
Seq and control reads, and then quantitatively and qualitatively analyzing number of called
peaks by standard workflow and Map2Peak.
4.4.1 Computation time
The computation time to generate peak list from unmapped ChIP-Seq and control reads
by Map2Peak was compared with that of standard workflow (see Table 4.3). The com-
putation time for standard workflow includes time to map ChIP and control datasets on
the whole genome, and the peak calling time. Map2Peak was consistently faster than the
standard workflow. On average, Map2Peak was twice as fast as standard workflow. All
the computations in this study were performed on the Intel R© Xeon CPU@E5620 2.40GHz
CPU with 12GB of RAM. Map2Peak achieves this reduction in computation time during
Phase 3 and Phase 4 of Map2Peak. During Phase 3 and Phase 4, Map2Peak maps ChIP-Seq
reads and maps majority of control reads on a much shorter pseudo-genome respectively
(Table 4.3) with exact mapping (no mismatches). Exact mapping occurs in linear time, i.e.,
(O(readlength)). In Table 4.3, we observe that approximately 70% of the ChIP-Seq reads
map to a much smaller genome (1-10% of original genome). Note, that the percentage of
control reads mapped on to the pseudo-genome is same as the percentage of ChIP reads
mapped on the pseudo-genome. Also, majority of control reads are mapped on to pseudo-
genome and computation effort is saved during mapping. Next, we would like to check how
this reduction in computation time by Map2Peak affects the number of peaks called.
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4.4.2 Peaks
In this section we compare the number of peaks called by Map2peak and standard work-
flow. In Table 4.4, we observe that Map2Peak calls similar number of peaks as that in
standard workflow. To compare the similarity and novelty of Map2Peak peaks with standard
workflow peaks, we classify peaks into three categories - peaks called by both Map2Peak
and standard workflow are referred to as common peaks, peaks called by Map2Peak and not
called by standard workflow are referred to as Map2Peak exclusive peaks and peaks called
by standard workflow and not called by Map2Peak are referred to as MACS2 exclusive peaks
(Figure 4.1). We call two peaks to be same if they have any overlap in their genomic location.
ENCODE accession
Number of peaks
called by Map2Peak
Number of peaks called
by standard workflow
ENCFF372SMO 5410 3673
ENCFF943NVH 24022 26261
ENCFF137XSL 6574 7881
ENCFF469MGV 23931 26327
ENCFF221INE 11122 11249
ENCFF779OCL 11684 12736
ENCFF052ZGR 5873 5979
ENCFF379ZPU 24152 28155
ENCFF446UUV 42718 46419
ENCFF215QBP 13723 17471
Table 4.4: Number of peaks called by Map2Peak and standard workflow
In Figure 4.1, we observe that Map2Peak captured majority (88%-96%) of the peaks
called by standard workflow (common peaks), missed some (4%-12%) peaks called by stan-
dard workflow (MACS2 exclusive peaks) and calls some novel peaks which were not called
by standard workflow (Map2Peak exclusive). To understand the statistical significance of
the MACS2 exclusive (missed peaks), we plot the box plots of log(p.value) for the MACS2
exclusive peaks and the common peaks (Figure 4.2 and 4.3). We observed that the MACS2
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exclusive peaks are less significant, i.e., have higher p.value (Figure 4.2 and 4.3) than the
common peaks. Hence, Map2Peak misses statistically less significant peaks.
Figure 4.1: Standard workflow peaks vs Map2Peak peaks: Peaks called by MACS2 and
Map2Peak were categorized into MACS2 exclusive (called only by standard workflow),
common peaks (called by both Map2Peak and standard workflow) and Map2Peak exclu-
sive (called only by Map2Peak). Map2Peak calls majority of standard workflow peaks while
missing some of the standard workflow peaks and calling some novel peaks which were not
called by standard workflow.
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Figure 4.2: Common peaks vs MACS2 exclusive peaks: To compare statistical significance
comparison of common peaks and MACS2 exclusive peaks boxplot of − log(p.value) for
common peaks and MACS2 exclusive peaks was plotted for datasets with read length of
76nt. We observe that MACS2 exclusive peaks (missed by Map2Peak) are less significant
than the common peaks.
Figure 4.3: Common peaks vs MACS2 exclusive peaks: To compare statistical significance
comparison of common peaks and MACS2 exclusive peaks boxplot of − log(p.value) for
common peaks and MACS2 exclusive peaks was plotted for datasets with read length of
50nt. We observe that MACS2 exclusive peaks (missed by Map2Peak) are less significant
than the common peaks.
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4.4.3 Motif analysis of common peaks and Map2Peak exclusive peaks
In Figure 4.1, we observed that Map2Peak calls some novel peaks (Map2Peak exclu-
sive peaks). To verify the veracity of these Map2Peak exclusive peaks, we performed mo-
tif analysis on common peaks and Map2Peak exclusive peaks to check if common peaks
and Map2peak exclusive peaks share a motif. The motif analysis was performed using
MEME-ChIP [81] and TOMTOM suite [82]. To perform this analysis, for each dataset
we selected 500 most statistically significant peaks from common peaks and Map2Peak
exclusive peaks, respectively. In each of the 500 peaks, we searched for 3 most sig-
nificant motifs using MEME-ChIP and then searched for a significant common motif in
Map2Peak exclusive and common peaks using TOMTOM. In figure 4.4 and 4.5, we de-
pict the common motifs with a p.value score. For each dataset in figure 4.4 and 4.5,
on top is the significant motif present in common peaks and below is a similar sig-
nificant motif present in Map2peak exclusive peaks. We observe that for each dataset
we have statistically significant similar motif between common and Map2Peak exclu-
sive peaks. Datasets ENCFF372SMO, ENCFF221INE, ENCFF052ZGR, ENCFF446UUV,
ENCFF943NVH, ENCFF469MGV, ENCFF379ZPU and ENCFF215QBP share highly sim-
ilar motif. This shows that Map2Peak exclusive peaks are not false positive peaks. Next
we investigate the cause behind Map2Peak exclusive peaks in Map2Peak workflow. We
first look for the change in read pileup at summit location for Map2peak exclusive peaks in
Map2Peak workflow when compared to standard workflow.
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Figure 4.4: Map2Peak exclusive peaks vs common peak motifs: For each dataset of read
length 76nt, we show the presence of significant common peak motif in 500 most significant
common peaks and in 500 most significant Map2Peak exclusive peaks. For each dataset,
motif present in common peaks is shown above the motif present in the Map2Peak exclusive
peaks, and on left similarity significance score is shown.
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Figure 4.5: Map2Peak exclusive peaks vs common peak motifs: For each dataset of read
length 50nt, we show the presence of significant common peak motif in 500 most significant
common peaks and in 500 most significant Map2Peak exclusive peaks. For each dataset,
motif present in common peaks is shown above the motif present in the Map2Peak exclusive
peaks, and on left similarity significance score is shown.
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4.4.4 Fragment pileup at summit location of Map2Peak exclusive peaks in standard
workflow and Map2Peak workflow
We investigated the change in fragment pileup at the summit location of Map2Peak exclu-
sive peaks in standard workflow and Map2Peak. For each ChIP-Seq dataset, we calculated
the fragment pileup at summit location for Map2Peak exclusive peaks by using the alignment
files generated by Map2Peak and standard workflow. We compared the fragment pileup at
summit locations calculated using Map2Peak alignment files with fragment pileup calcu-
lated using standard workflow alignment files (Figure 4.7 and 4.6). In Figure 4.7 and 4.6,
we observe that the fragment pileup at summit of Map2Peak exclusive peaks for Map2peak
is higher than the standard workflow. This increase in pileup is because of the recovery of
some multi-mappable reads in Phase 3 of Map2Peak. We show this in the next section.
Figure 4.6: Pileup at Map2peak exclusive peaks-1: We compare the fragment pileup at sum-
mit location of Map2Peak exclusive peaks calculated using Map2Peak and standard work-
flow alignment files, respectively. It is observed that pileup at summit location of Map2Peak
exclusive peaks is higher for Map2peak compared to standard workflow.
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Figure 4.7: Pileup at Map2peak exclusive peaks-2: We compare the fragment pileup at sum-
mit location of Map2Peak exclusive peaks calculated using Map2Peak and standard work-
flow alignment files, respectively. It is observed that pileup at summit location of Map2Peak
exclusive peaks is higher for Map2peak compared to standard workflow.
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4.5 Map2Peak resolves multi-mappable read locations and calls peaks in repeat ele-
ments of the genome
In this section, we assess the capability of Map2Peak to resolve the alignment location
of multi-mappable reads, their role in discovery of Map2peak exclusive peaks, and increase
in power to call peaks in repeat elements of the genome.
4.5.1 Multi-mappable reads contribute to Map2Peak exclusive peaks
During Phase 3, reads are aligned exactly on the pseudo-genome, which is much shorter
than the whole genome (Table 4.3). Some of the alignment locations for multi-mappable
reads get discarded during Phase 2. Therefore, some of the multi-mappable reads (based on
the whole genome) get mapped uniquely to the pseudo-genome. The number of recovered
multi-mappable reads (in Phase 3) were 5−10% (Table 4.5) which play a role in the discovery
of novel peaks, i.e., Map2Peak exclusive peaks (Table 4.5). We quantified the contribution
of these recovered multi-mappable reads towards Map2Peak exclusive peaks and common
peaks (Table 4.5). We observe that the recovered multi-mappable reads contribution per
peak is much higher for Map2Peak exclusive peaks than common Peaks (Table 4.5) which
indicates that the Map2Peak exclusive peaks are not false positives and are called during peak
calling because of the increased fragment pileup due to recovered multi-mappable reads.
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4.5.2 Map2Peak discovers peaks in repetitive elements of genome
The resolved multi-mappable reads in Phase 3 empowers Map2peak to call peaks in the
repeat elements of DNA. We analyzed the enrichment of Map2Peak exclusive peaks for
different classes of repeat elements, i.e., Short INterspersed Elements (SINE), Long INter-
spersed Elements (LINE), DNA Transposons (DNA), Long Terminal Repeats (LTR) and
segmental duplication repeat elements. We have used the repeat masker BED and segmen-
tal duplications BED file from UCSC [83] to perform this analysis. Map2Peak exclusive
peaks and common peaks were overlapped with repeat elements BED files. We observe that
the percentage of Map2Peak Peaks overlapping with repeat elements of genome is equal
or higher than the percentage of common peaks overlapping with repeat elements (Figure
4.8 and 4.9), which proves the utility of multi-mappable reads recovered by Map2Peak in
identifying binding sites in repeat elements of the genome.
We observe that for datasets ENCFF779OCL, ENCFF052ZGR, ENCFF215QBP,
ENCFF137XSL, the percentage of Map2Peak exclusive peaks overlapping with repeat ele-
ments is higher than the percentage of common peaks reads overlapping with repeat elements
and for datasets ENCFF379ZPU, ENCFF446UUV, ENCFF372SMO, ENCFF943NVH,
ENCFF469MGV, ENCFF221INE, the percentage of Map2Peak exclusive peaks overlapping
with repeat elements of genome is same as the percentage of common peaks reads overlap-
ping with repeat elements of genome.
Also, we performed motif analysis on Map2Peak exclusive peaks which overlap with
repeat elements of the genome. The motif analysis was performed using MEME-ChIP [81]
and TOMTOM suite [82]. To perform this analysis, for each dataset we selected 500 most
statistically significant peaks from common peaks and Map2Peak exclusive peaks (in repeat
elements), respectively. In each of the 500 peaks, we searched for 3 most significant motifs
using MEME-ChIP and then searched for a significant common motif in Map2Peak exclu-
sive (in repeat elements) and common peaks. In Figure 4.10 and 4.11, we depict the common
motifs with a p.value score. For each dataset in Figure 4.10 and 4.11, on top is the signif-
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icant motif in common peaks and below is a similar significant motif present in Map2peak
exclusive peaks (in repeat elements). We observe that for each dataset we have statisti-
cally significant similar motif between common and Map2Peak exclusive peaks (in repeat
elements). Datasets ENCFF372SMO, ENCFF221INE, ENCFF379ZPU, ENCFF446UUV,
ENCFF943NVH, ENCFF469MGV, ENCFF379ZPU and ENCFF215QBP share highly sim-
ilar motif. This proves that the Map2peak exclusive peaks overlapping with repeat elements
of genome are not false positive peaks.
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Figure 4.8: Map2Peak exclusive and common peaks overlapping with repeat elements for
dataset of read length 76nt: Map2Peak exclusive peaks and common peaks were classified
into peaks which overlap with SINE, LINE, LTR, DNA repeat and segmental duplication
elements. Equal or higher percentage of Map2peak exclusive peaks overlap with repeat
elements than common peaks.
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Figure 4.9: Map2Peak exclusive and common peaks overlapping with repeat elements for
dataset of read length 50nt: Map2Peak exclusive peaks and common peaks were classified
into peaks which overlap with SINE, LINE, LTR, DNA repeat and segmental duplication
elements. Equal or higher percentage of Map2peak exclusive peaks overlap with repeat
elements than common peaks.
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Figure 4.10: Map2Peak exclusive peaks (in repeat elements) vs common peak motifs: For
each dataset of read length 76nt, we show the presence of significant common peak motif in
500 most significant common peaks and in 500 most significant Map2Peak exclusive peaks.
For each dataset, common peaks motif is shown above Map2Peak exclusive peaks motif and
on left similarity significance score.
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Figure 4.11: Map2Peak exclusive peaks (in repeat elements) vs common peak motifs: For
each dataset of read length 50nt, we show the presence of significant common peak motif in
500 most significant common peaks and in 500 most significant Map2Peak exclusive peaks.
For each dataset, common peaks motif is shown above Map2Peak exclusive peaks motif and
on left similarity significance score.
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5. SENSITIVITY ANALYSIS
In this chapter, we performed sensitivity analysis to quantify the effect of parameter
settings on Map2Peak’s performance. We quantify the effect of parameters, -T (island satu-
ration to move from phase 1 to phase 2) and -E (EM cutoff used to select pseudo-genome).
5.1 T: Island saturation
Parameter -T (island saturation) is used to pause ChIP-Seq read alignment in Phase 1 and
move Map2Peak algorithm to Phase 2. In Table 5.1 and 5.2, we have recorded the results of
varying parameter, -T on the size pseudo-genome of selected in Phase 2, computation time to
call peaks, number of reads mapped in Phase 1 and number of common peaks (peaks called
by Map2peak and standard workflow). We observe that for each dataset, as we increase the
value of island saturation (-E) the number of reads mapped in Phase 1 decreases. Because of
the reduction in number of reads mapped in Phase 1 there are fewer ChIP enriched regions
after Phase 1 and hence the size of the pseudo-genome selected during Phase 2 decreases.
Because of the reduction in size of pseudo-genome, the indexing time for pseudo-genome
during Phase 2 reduces. Also as the number of reads in Phase 1 reduces, more number
of ChIP-Seq and control reads are mapped on to pseudo-genome and hence mapping time
during phase 3 and control reads in Phase 4 also decreases. So, in total the computation time
reduces which we note in Table 5.1 and 5.2. Finally, we observe that as the island threshold
increases the number of peaks called by Map2Peak and the number of common peaks (called
by Map2Peak and standard workflow reduces) reduces. This happens because of the fewer
ChIP enriched regions after Phase 1 as the island threshold increases. We recommend the
user to map more reads in Phase 1 (decrease the value of island threshold) to achieve more
common peaks with standard workflow and for faster computation time map fewer reads in
Phase 1 but note that that there might fewer peaks called by Map2Peak.
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5.2 E: EM cutoff to classify bins into enriched genomic regions
During Phase 2 of Map2peaks algorithm, after EM algorithm converges, we use param-
eter -E (EM cutoff) to select a pseudo-genome. In Table 5.3 and 5.4, we have recorded the
results of varying parameter, -E on the size of the pseudo-genome selected in Phase 2, com-
putation time to call peaks, number of peaks called by Map2Peak and number of common
peaks (peaks called by Map2peak and standard workflow). We observe that for each dataset,
as we increase the value of EM cutoff (-E) the size of the pseudo-genome selected during
Phase 2 decreases. Because of the reduction in size of pseudo-genome, the indexing time for
pseudo-genome during Phase 2 reduces. Also, as the number of reads in phase-1 reduces,
more number of ChIP-Seq and control reads are mapped on to pseudo-genome and hence
mapping time during Phase 3 and control reads in Phase 4 also decreases. So, in total the
computation time reduces which we note in Table 5.3 and 5.4. Finally, we observe that as the
EM cutoff increases the number of peaks called by Map2Peak and the number of common
peaks (called by Map2Peak and standard workflow reduces) reduces. This happens because
of the reduction in size of pseudo-genome.
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Dataset EM
cutoff
Computation
time
Pseudo genome size
Number of
peaks
called by
Map2Peak
Number of
common peaks
E
N
C
FF
77
9O
C
L 1 39m38s (0.45) 61813891 (2.06%) 11123 11303 (88.74%)
0.9 40m57s (0.47) 96171956 (3.20%) 11684 11574 (90.87%)
0.8 42m22s (0.49) 96171956 (3.20%) 11684 11574 (90.87%)
0.7 42m20s (0.49) 96171956 (3.20%) 12158 11574 (90.87%)
0.6 46m19s (0.54) 191910067 (6.39%) 12158 11674 (91.66%)
0.5 45m55s (0.54) 191910067 (6.39%) 12158 11674 (91.66%)
E
N
C
FF
05
2Z
G
R 1 39m18s (0.43) 32755225 (1.09%) 5358 5321 (88.99%)
0.9 44m33s (0.49) 106641786 (3.55%) 5873 5471 (91.50%)
0.8 44m20s (0.49) 106641786 (3.55%) 5873 5471 (91.50%)
0.7 50m55s (0.56) 265396788 (8.84%) 6137 5507 (92.10%)
0.6 51m05s (0.56) 265396788 (8.84%) 6137 5507 (92.10%)
0.5 51m00s (0.56) 265396788 (8.84%) 6137 5507 (92.10%)
E
N
C
FF
37
9Z
PU 1 53m18s (0.39) 46636778 (1.55%) 22080 23627 (83.91%)
0.9 54m59s (0.41) 57627968 (1.92%) 24152 25112 (89.19%)
0.8 56m25s (0.41) 81478669 (2.71%) 26007 26074 (92.60%)
0.7 55m33s (0.41) 81478669 (2.71%) 26007 26074 (92.60%)
0.6 55m42s (0.41) 81478669 (2.71%) 26007 26074 (92.60%)
0.5 55m56s (0.41) 81478669 (2.71%) 26007 26074 (92.60%)
E
N
C
FF
44
6U
U
V 1 43m47s (0.50) 115891418 (3.86%) 40044 40376 (86.98%)
0.9 46m16s (0.54) 159148275 (5.30%) 44530 42718 (92.02%)
0.8 49m46s (0.57) 244806792 (8.16%) 44530 44128 (95.06%)
0.7 50m03s (0.58) 244806792 (8.16%) 47601 44128 (95.06%)
0.6 49m39s (0.58) 244806792 (8.16%) 47601 44128 (95.06%)
0.5 50m05s (0.58) 244806792 (8.16%) 47601 44128 (95.06%)
E
N
C
FF
77
9O
C
L 1 34m36s (0.47) 46981885 (1.56%) 13243 16425 (94.01%)
0.9 36m24s (0.50) 54931155 (1.83%) 13723 16728 (95.74%)
0.8 37m28s (0.51) 71532355 (2.38%) 14068 16916 (96.82%)
0.7 37m21s (0.51) 71532355 (2.38%) 14068 16916 (96.82%)
0.6 37m58s (0.51) 71532355 (2.38%) 14068 16916 (96.82%)
0.5 37m32s (0.51) 71532355 (2.38%) 14068 16916 (96.82%)
Table 5.3: Effect of parameter, EM cutoff (-E) for datasets with read length of 50nt on
computation time, number of Map2Peak peaks, number of common peaks (peaks called by
Map2Peak and standard workflow) and size of pseudo-genome selected during Phase-2.
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Dataset EM
cutoff
Computation
time
Pseudo genome size
Number
of peaks
called by
Map2Peak
Number of
common peaks
E
N
C
FF
37
2S
M
O 1 34m56s (0.45) 23494323 (0.78%) 3398 2678 (72.91%)
0.9 40m48s (0.53) 156605371 (5.22%) 5410 3279 (89.27%)
0.8 55m41s (0.73) 420978942 (14.03%) 5925 3347 (91.12%)
0.7 54m17s (0.72) 420978942 (14.03%) 5925 3347 (91.12%)
0.6 80m05s (1.06) 890853907 (29.69%) 6041 3358 (91.42%)
0.5 79m50s (1.06) 890853907 (29.69%) 6041 3358 (91.42%)
E
N
C
FF
94
3N
V
H 1 59m07s (0.48) 37637487 (1.25%) 22690 23005 (87.60%)
0.9 59m38s (0.48) 41527352 (1.38%) 24022 24149 (91.95%)
0.8 59m52s (0.48) 41527352 (1.38%) 24022 24149 (91.95%)
0.7 59m52s (0.48) 41527352 (1.38%) 24022 24149 (91.95%)
0.6 58m35s (0.47) 41527352 (1.38%) 24022 24149 (91.95%)
0.5 60m20s (0.49) 51219797 (1.70%) 24959 25117(95.64%)
E
N
C
FF
13
7X
SL 1 72m05s (0.44) 39134976 (1.30%) 5870 6778 (86.00%)
0.9 82m32s (0.50) 209724066 (6.99%) 6574 7140 (90.59%)
0.8 82m50s (0.50) 209724066 (6.99%) 6574 7140 (90.59%)
0.7 82m58s (0.50) 209724066 (6.99%) 6574 7140 (90.59%)
0.6 101m25s (0.62) 512696407 (17.08%) 6584 7163 (90.88%)
0.5 101m37s (0.62) 512696407 (17.08%) 6584 7163 (90.88%)
E
N
C
FF
46
9M
G
V 1 57m42s (0.48) 37263470 (1.24%) 22547 22838 (86.74%)
0.9 58m42s (0.48) 41073563 (1.36%) 23931 24032 (91.28%)
0.8 58m38s (0.48) 41073563 (1.36%) 23931 24032 (91.28%)
0.7 57m44s (0.48) 41073563 (1.36%) 23931 24032 (91.28%)
0.6 57m19s (0.48) 41073563 (1.36%) 23931 24032 (91.28%)
0.5 58m56s (0.48) 50725681 (1.69%) 25148 24951 (94.77%)
E
N
C
FF
22
1I
N
E 1 75m34s (0.43) 84314936 (2.81%) 8728 9061 (80.54%)
0.9 92m59s (0.53) 302486652 (10.08%) 11113 9873 (87.76%)
0.8 109m22s (0.63) 607005531 (20.23%) 11417 9924 (88.22%)
0.7 109m37s (0.63) 607005531 (20.23%) 11417 9924 (88.22%)
0.6 108m21s (0.63) 607005531 (20.23%) 11417 9924 (88.22%)
0.5 136m49s (0.79) 1065495591 (35.51%) 11012 9916 (88.15%)
Table 5.4: Effect of parameter, EM cutoff (-E) for datasets with read length of 76nt on
computation time, number of Map2Peak peaks, number of common peaks (peaks called by
Map2Peak and standard workflow) and size of pseudo-genome selected during Phase-2.
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6. DISCUSSION AND SUMMARY
In this dissertation, we developed a novel methodology called Map2Peak which takes a
new perspective on the overall ChIP-Seq data analysis workflow. Map2Peak removes some
major inherent deficiencies of the standard tandem workflow by proposing a fundamentally
different approach. Map2Peak intertwines the process of read mapping and peak calling.
During early stages of ChIP-Seq read mapping, Map2Peak identifies the pseudo-genome,
i.e., the ChIP-read enriched genomic regions which are more likely to contain TF-DNA
binding sites. Once the pseudo-genome is identified the remaining ChIP-Seq reads and ma-
jority of control reads are mapped to pseudo-genome. The read mapping is followed by peak
calling on pseudo-genome. Because the size of pseudo-genome is small compared to the
original genome and the mapping on the pseudo-genome is performed with no mismatches
majority of ChIP-Seq and control reads do not map to the pseudo-genome. Indentifying that
the read do not map to pseudo-genome happens in linear time, i.e, (O(readlength)). In fact,
we showed in results chapter that reads which do not map on the pseudo-genome are the
background reads which are present in ChIP-Seq dataset.
As a result, Map2Peak is capable of correctly discarding the majority of background
reads and reduces the computational time between unmapped ChIP and control reads to
peaks by half. In comparison with peaks called by the standard workflow, Map2Peak only
missed a small number of binding sites with lower significance compared to the peaks called
by both standard workflow and Map2Peak. In Phase 3, Map2Peak implicitly resolved align-
ment location for some of the multi-mappable reads which increased the pileup at the loca-
tion of novel peaks and hence consequently led Map2Peak to identify novel binding sites
which were missed by standard workflow. It was observed that the contribution of re-
solved multi-mappable reads is higher towards novel peaks than the peaks called by standard
worklflow and Map2Peak. These novel peaks had a similar motif to those of common peaks
between Map2Peak and standard workflow.
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Identifying binding sites in the repeat elements is problematic as the ChIP-Seq reads orig-
inating from them may not be aligned uniquely by the read mapper. Furthermore, standard
worklflow discards multi-mappable reads from the analysis. Map2Peak implicitly resolves
alignment location for some of the multi-mappable reads as major portions of the genome
is discarded in Phase 2, and thereby, eliminates the majority of repeat elements. This forces
some of the multi-mappable reads to become uniquely mappable on the pseudo-genome.
Consequently, Map2Peak has increased power in identifying binding sites in repeat elements
of the genome. We observed that higher or equal percentage of novel peaks overlap with the
peaks called by both standard workflow and Map2Peak. We also observed that the novel
peaks which overlap with repeat elements share a common motif with peaks called by both
standard workflow and Map2Peak.
Map2Peak provides researchers with a fast and accurate peak caller which utilizes whole
ChIP-Seq dataset without discarding multi-mappable reads to identify transcription-DNA
interactions sites in repeat regions of genome in addition to non-repeat regions of genome,
and efficiently utilizes control datasets for the purpose of peak calling. Map2Peak elimi-
nates the need for using separate tools for read mapping and peak calling. Bioinformati-
cians will be able to perform read mapping and peak calling simultaneously. Although
this research is focused on ChIP-Seq datasets, the ideas developed can be used to de-
velop similar approaches for other NGS datasets. The software “Map2Peak” is available
at https://kianfar.engr.tamu.edu/map2peak/.
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APPENDIX A
SUPPLEMENTARY INFORMATION
A.1 Fragment length estimation
In Phase 2, fragment length was estimated. To estimate the fragment length, first signal
profile for Watson and Crick strand is built by counting the number of mapped ChIP-Seq
reads at each genomic location. Fragment length is estimated by calculating cross-correlation
between Watson and Crick strand signal profiles. Inherently signal profile for Crick Strand
lags Watson strand. Hence, Crick strand is shifted towards 5’ to 3’ direction and at each value
of shift cross-correlation is calculated. The shift at which cross-correlation attains maxima
is optimal shift and an estimate of fragment length. Cross correlation plot for each dataset
is shown in Figure A.1. For datasets ENCFF221INE and ENCFF372SMO, we have a local
maxima at shift size equal to read length. These peaks are known as “phantom” peaks [42].
In a high-quality Immuno-Precipitation , the ChIP peak is much higher than the “phantom”
peak, while very small or no ChIP peaks are seen in failed ChIP experiments.
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Figure A.1: Cross-Correlation plots: For each dataset, we plot cross correlation of read count
between watson and crick strand at shift of crick strand in 5′to 3′direction
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A.2 Convergence of EM algorithm
In E-M algorithm, LogLikelihood value converges to a local maxima in finite number of
iterations. In Figure A.2, we show that for each dataset Loglikelihood converges in finite
number of iterations.
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Figure A.2: Convergence plots: For each dataset, we plot the loglikelihood at each of E-M
algorithm’s iteration. loglikelihood converges to a local maxima in finite number of iterations
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A.3 Read Island Saturation
In Phase 1 of Map2Peak’s algorithm, we map ChIP-Seq reads until read island saturation
is achieved. For each dataset, we have plotted the number of mapped ChIP-Seq reads on
the x-axis and incremental increase in number of read islands with respect to incremental
increase of mapped reads on the y-axis (Figure A.3 and A.4). We observe that as more
ChIP-Seq reads get mapped the incremental increase in number of read islands with respect
to incremental increase of mapped reads keeps decreasing.
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Figure A.3: Read Island Saturation plots-1: For each dataset, we plot the number of mapped
ChIP-Seq reads on the x-axis and incremental increase in number of read islands with respect
to incremental increase of mapped reads on the y-axis. We observe that as more ChIP-
Seq reads get mapped the incremental increase in number of read islands with respect to
incremental increase of mapped reads keeps decreasing.
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Figure A.4: Read Island Saturation plots-2: For each dataset, we plot the number of mapped
ChIP-Seq reads on the x-axis and incremental increase in number of read islands with respect
to incremental increase of mapped reads on the y-axis. We observe that as more ChIP-
Seq reads get mapped the incremental increase in number of read islands with respect to
incremental increase of mapped reads keeps decreasing.
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APPENDIX B
MAP2PEAK MANUAL
B.1 Input files and output files
The input files required by Map2Peak:
• ChIP-Seq read file (FASTQ).
• control read file (FASTQ).
• Bowtie index of reference genome.
The output file are
• Bed file containing peak locations.
• Alignment file.
B.2 Installation
You may download Map2Peak binary directly from downloads section below and add the
folder containing binary to PATH or you can download the source files from downloads
section. To build from source
1. extract the source files
2. go to source files folder
3. run make
$ make
4. run make install
$ sudo make install
92
B.3 Map2Peak Parameters
1. -D: Name of the control file.
2. -V: p.value cutoff for peak calling.
Default value is 1e-5.
Smaller the value of p.value more statistically significant are the called peaks.
3. -N: name string to create output files after peak
calling.
Default is "".
4. -R: fraction of total Chip-Seq reads. After every "R"
number of reads are aligned Map2Peak checks for read
density saturation. Default is 0.01.
5. -T: Threshold to check read saturation. Once this
threshold is achieved, Map2Peak moves to Phase 2.
Default is 0.02.
As the value of T is increased Map2Peak becomes slower and more number of reads
are mapped in Phase 1 of Map2Peak.
6. -E: Membership probability cutoff to classify genomic
regions
into background or Signal. Default is 0.9.
The cutoff value should be in between 0.5 and 1. The lower the value of membership
probability, the larger the pseudogenome, i.e., Phase 3 genome and slower Map2Peak
computations.
7. -g: used to set the genome. Default is "hs" for human
genome. You can set it equal to “mm” for Mouse , “ce” for C. elegans and “dm” for
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Drosophilia melanogaster.
The lower the value of membership probability, the larger the pseudogenome ,i.e.,
Phase 3 genome and slower Map2Peak computations.
8. -L: used to set the fragment length of ChIP library.
Map2Peak will use this value instead of estimating the fragment length.
B.4 Working Example
1. Download and extract ChIP-Seq file.
$ wget -q ’https://www.encodeproject.org/files/ENCFF469MGV
/@@download/ENCFF469MGV.fastq.gz’;
$ gunzip ENCFF469MGV.fastq.gz;
2. Download and extract control file.
$ wget -q ’https://www.encodeproject.org/files/ENCFF295VZD
/@@download/ENCFF295VZD.fastq.gz’;
$ unzip ENCFF295VZD.fastq.gz;
3. Download hg19 index.
$ wget -q ’ftp://ftp.ccb.jhu.edu/pub/data/bowtie_indexes
/hg19.ebwt.zip’;
$ unzip hg19.ebwt.zip;
4. run Map2Peak
$ Map2Peak -v 2 -m 1 -best -strata -D ControlDirectory/
ENCFF295VZD.fastq -N MGV directory/hg19 ChIPDirectory/
ENCFF469MGV.fastq -S ENCFF469MGV.sam;
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Notes:
1. "directory" is the location of hg19 bowtie index file.
2. "ChIPDirectory" is the location of ChIP-Seq fastq file.
3. "ChIPDirectory" is the location of Control fastq file.
4. Important: Use only single fastq files for control and ChIP-Seq.
5. Peak output file will be "MGVPeaks.bed".
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